|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 493/06 | |
| A61K 31/352 | |||
| A61P 35/00 |
| (11) | Number of the document | 2721035 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12728260.6 |
| Date of filing the European patent application | 2012-06-15 | |
| (97) | Date of publication of the European application | 2014-04-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/061485 |
| Date | 2012-06-15 |
| (87) | Number | WO 2012/172069 |
| Date | 2012-12-20 |
| (30) | Number | Date | Country code |
| 201161497215 P | 2011-06-15 | US |
| (72) |
SCHEFFLER, Björn, DE
GLAS, Martin, DE
SIMON, Matthias, DE
GOGOLOK, Sabine, DE
TRAGESER, Daniel, DE
REINARTZ, Roman, DE
WIELAND, Anja, DE
|
| (73) |
Life & Brain GmbH,
Sigmund-Freud-Stra e 25, 53127 Bonn,
DE
Rheinische Friedrich-Wilhelms-Universität, Regina-Pacis-Weg 3, 53113 Bonn, DE |
| (54) | GLIOBLASTOMA INHIBITING COMPOUNDS AND THEIR USE |
| GLIOBLASTOMA INHIBITING COMPOUNDS AND THEIR USE |